[Transient myasthenia gravis neonatorum with demonstration of muscle-specific antibodies].
D000328:Adult; D000906:Antibodies / Q000032:analysis*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins / Q000032:analysis; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000235:genetics*; D008297:Male; D009132:Muscles / Q000276:immunology*; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012121:Respiration, Artificial
D000906:Antibodies; D007136:Immunoglobulins; D011729:Pyridostigmine Bromide
Myasthenia gravis neonatorum transitoria mit Nachweis muskelspezifischer Antikörper.